Creades
Creades AB is a Swedish investment company based in Stockholm that owns and manages a portfolio of listed and unlisted holdings. It acts as a long-term engaged owner, mainly in smaller and mid-sized Nordic companies, and also actively manages selected listed investments.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueDirect investments in smaller and mid-sized listed and unlisted companies.
Active management of quoted holdings with long-term upside potential.
Returns from dividends, distributions, and realized gains on investments.
Customers
Creades does not sell products to end consumers; its capital is deployed into portfolio companies and its economic return comes from those investments. Its counterparties are founders, owners, management teams, boards, and other shareholders in Nordic companies where it can take an active ownership role. The company also serves Creades' own shareholders by seeking risk-adjusted returns through capital growth and investment income.
They sell minority or majority stakes to Creades for capital and an active long-term owner
They partner with Creades in quoted holdings where it seeks long-term revaluation
They work with Creades on growth, efficiency, and strategic development
They buy Creades shares to gain exposure to the investment portfolio
Strategy
Creades seeks opportunistic investments where it can act as an engaged owner and help build long-term value. Its strategy combines ownership influence, active portfolio management, and a preference for businesses with predictable customer behavior and room for revaluation.
Influence can improve strategy, operations, and capital allocation
The mandate targets companies where engaged ownership can matter most
Returns depend on both multiple expansion and business improvement
Geography
Creades is headquartered in Stockholm and its investment focus is primarily Sweden and the wider Nordic region. The portfolio can also include listed holdings with broader geographic exposure, but the core mandate remains Nordic and especially Swedish companies.
Risks
Creades is exposed to market risk because the value of its portfolio can move with equity prices and valuation multiples. As an investment company, it also depends on the performance of a concentrated set of holdings, so company-specific setbacks in portfolio businesses can materially affect results.
- Market risk in portfolio valuationsImpact: HighLikelihood: Medium
Equity and private-market values fluctuate with market sentiment and fundamentals
Exposure: Listed and unlisted holdings
- Concentration riskImpact: HighLikelihood: Medium
A few large holdings can dominate net asset value and returns
Exposure: Portfolio construction
- Valuation and liquidity risk in unlisted assetsImpact: MediumLikelihood: Low
Fair values rely on estimates and exits may take time
Exposure: Private investments
- Currency riskImpact: MediumLikelihood: Low
Underlying portfolio companies may have foreign-currency exposure
Exposure: Indirect through holdings
Accounting
Judgemental itemsReported earnings depend on valuation changes in listed and unlisted holdings
Impact: Can create large unrealized gains or losses
Portfolio companies are not consolidated, changing presentation versus operating groups
Impact: Results reflect investment returns rather than line-by-line operating revenue
Unlisted holdings are measured at fair value using judgmental inputs
Impact: Valuation assumptions can materially affect NAV and profit
Similar listed companies
Publicly listed companies with a comparable business focus.
Healthier Choices Management Corp.
HCMC · Tobacco Products
Hong Yuan Holding Group
HGYN · Plastic Materials, Synth Resins & Nonvulcan Elastomers
HONG YUAN HOLDING GROUP is a U.S.-listed company in the plastics and synthetic resins value chain.
Valuence Merger Corp. I
VMCUF · Blank Checks
Valuence Merger Corp.
American Exceptionalism Acquisition Corp. A
AEXA · Blank Checks
American Exceptionalism Acquisition Corp.
Artificial Intelligence Technology Solutions Inc.
AITX · Services-Prepackaged Software
Amgen Inc
AMGN · Biological Products, (No Diagnostic Substances)
Last updated: 24/09/2026